| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,977 |
23,111 |
$9.07M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,054 |
26,952 |
$8.59M |
| G0378 |
Hospital observation service, per hour |
3,169 |
2,723 |
$2.92M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,978 |
5,494 |
$1.58M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,998 |
7,597 |
$1.47M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,377 |
765 |
$1.25M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,097 |
1,043 |
$927K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
20,339 |
4,475 |
$887K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,770 |
8,739 |
$579K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
548 |
532 |
$498K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
10,638 |
2,668 |
$427K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,281 |
14,245 |
$404K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,742 |
3,138 |
$372K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,235 |
4,000 |
$362K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,304 |
11,677 |
$312K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
5,147 |
1,313 |
$264K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,847 |
1,288 |
$250K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,732 |
1,628 |
$235K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,484 |
5,115 |
$217K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
327 |
310 |
$216K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,679 |
7,776 |
$200K |
| 80053 |
Comprehensive metabolic panel |
37,469 |
30,136 |
$192K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
409 |
376 |
$185K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,144 |
3,974 |
$169K |
| OP370 |
|
2,973 |
2,765 |
$166K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,754 |
2,477 |
$157K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,436 |
5,041 |
$131K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,131 |
2,041 |
$125K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,667 |
31,148 |
$125K |
| 71046 |
Radiologic examination, chest; 2 views |
8,162 |
7,768 |
$109K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,711 |
6,314 |
$104K |
| 71045 |
Radiologic examination, chest; single view |
9,625 |
8,904 |
$86K |
| 95819 |
|
117 |
116 |
$85K |
| OP272 |
|
4,491 |
4,079 |
$82K |
| OP250 |
|
47,956 |
29,438 |
$80K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,901 |
6,309 |
$79K |
| 92587 |
|
398 |
387 |
$79K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,137 |
1,998 |
$79K |
| 93971 |
|
777 |
736 |
$73K |
| 97162 |
|
1,204 |
1,158 |
$67K |
| OP710 |
|
1,229 |
1,161 |
$65K |
| 92567 |
|
574 |
560 |
$59K |
| 90791 |
Psychiatric diagnostic evaluation |
3,953 |
3,354 |
$57K |
| 97010 |
|
12,793 |
3,020 |
$55K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,052 |
1,010 |
$48K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,113 |
369 |
$45K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,519 |
1,458 |
$45K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,111 |
942 |
$45K |
| 92557 |
|
153 |
151 |
$43K |
| 36415 |
Collection of venous blood by venipuncture |
34,289 |
27,610 |
$42K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,096 |
3,563 |
$42K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,680 |
5,099 |
$35K |
| 84484 |
|
9,313 |
7,365 |
$34K |
| 76830 |
Ultrasound, transvaginal |
796 |
766 |
$28K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
19 |
12 |
$25K |
| 81025 |
|
13,898 |
12,586 |
$25K |
| OP279 |
|
2,328 |
2,198 |
$25K |
| 95886 |
|
90 |
89 |
$25K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
440 |
420 |
$25K |
| 96376 |
|
2,269 |
1,842 |
$24K |
| 88313 |
|
1,078 |
1,017 |
$24K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,283 |
3,006 |
$21K |
| 81003 |
|
13,090 |
11,952 |
$21K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,118 |
1,013 |
$21K |
| 83690 |
|
10,372 |
9,343 |
$20K |
| 82077 |
|
5,123 |
4,437 |
$19K |
| 96367 |
|
124 |
100 |
$19K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
619 |
569 |
$19K |
| 73630 |
|
1,860 |
1,789 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,497 |
2,771 |
$18K |
| 83735 |
|
6,781 |
5,208 |
$18K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
263 |
214 |
$17K |
| 73610 |
|
1,617 |
1,557 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,064 |
3,673 |
$14K |
| OP258 |
|
22,087 |
15,526 |
$14K |
| 85610 |
|
5,989 |
5,355 |
$14K |
| 83880 |
|
2,254 |
2,069 |
$13K |
| 36591 |
|
114 |
70 |
$13K |
| 88312 |
|
1,005 |
961 |
$13K |
| 73130 |
|
1,466 |
1,408 |
$13K |
| 74019 |
|
1,329 |
1,240 |
$11K |
| 81001 |
|
10,480 |
9,385 |
$10K |
| 73030 |
|
1,149 |
1,090 |
$10K |
| 0012A |
|
365 |
365 |
$10K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,415 |
1,632 |
$10K |
| 85730 |
|
3,679 |
3,338 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
76 |
39 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,079 |
6,508 |
$10K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,600 |
1,270 |
$9K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
194 |
171 |
$9K |
| 86901 |
|
1,896 |
1,520 |
$9K |
| 86900 |
|
1,876 |
1,518 |
$9K |
| 0011A |
|
349 |
349 |
$9K |
| 82962 |
|
4,845 |
3,234 |
$9K |
| OP259 |
|
6,807 |
5,012 |
$8K |
| 87070 |
|
3,036 |
2,895 |
$8K |
| OP379 |
|
298 |
295 |
$8K |
| 82550 |
|
2,963 |
2,728 |
$8K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
16 |
14 |
$8K |
| 86885 |
|
1,319 |
1,030 |
$8K |
| 73562 |
|
843 |
800 |
$8K |
| 85027 |
|
2,194 |
1,781 |
$8K |
| 74018 |
|
885 |
845 |
$8K |
| 73110 |
|
703 |
663 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
201 |
178 |
$7K |
| 97163 |
|
108 |
102 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,936 |
3,618 |
$7K |
| 80143 |
|
1,976 |
1,759 |
$7K |
| 80179 |
|
1,899 |
1,693 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,079 |
5,115 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
3,269 |
2,554 |
$6K |
| 87040 |
|
847 |
777 |
$6K |
| 97161 |
|
111 |
111 |
$6K |
| 84100 |
|
3,013 |
2,559 |
$6K |
| 90715 |
|
620 |
596 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,089 |
1,747 |
$6K |
| 85379 |
|
2,326 |
2,186 |
$6K |
| 83605 |
|
2,287 |
2,008 |
$6K |
| 80061 |
Lipid panel |
1,617 |
1,471 |
$6K |
| 59025 |
Fetal non-stress test |
16 |
12 |
$5K |
| 73502 |
|
401 |
366 |
$5K |
| 72110 |
|
369 |
353 |
$5K |
| J2060 |
Injection, lorazepam, 2 mg |
2,557 |
2,062 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,831 |
3,677 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,670 |
2,046 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
231 |
174 |
$4K |
| 0064A |
|
126 |
122 |
$4K |
| J3490 |
Unclassified drugs |
1,165 |
950 |
$4K |
| 71250 |
|
55 |
51 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
41 |
41 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,810 |
1,767 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
536 |
494 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,849 |
6,637 |
$3K |
| 72100 |
|
312 |
299 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
81 |
80 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,045 |
504 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,198 |
1,067 |
$3K |
| 87088 |
|
852 |
816 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
347 |
221 |
$3K |
| 80306 |
|
1,124 |
1,009 |
$3K |
| 73564 |
|
153 |
150 |
$3K |
| 84702 |
|
728 |
629 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,604 |
1,485 |
$3K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,092 |
821 |
$2K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,739 |
1,240 |
$2K |
| 0002A |
|
62 |
62 |
$2K |
| 82728 |
|
545 |
458 |
$2K |
| 76770 |
|
70 |
62 |
$2K |
| OP270 |
|
1,084 |
1,016 |
$2K |
| 80320 |
|
396 |
363 |
$2K |
| 0004A |
|
51 |
51 |
$2K |
| 74021 |
|
210 |
208 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
13 |
12 |
$2K |
| 0001A |
|
42 |
42 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
39 |
39 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,328 |
1,001 |
$2K |
| 93970 |
|
15 |
15 |
$1K |
| 97035 |
|
538 |
121 |
$1K |
| 83789 |
|
747 |
656 |
$1K |
| 84145 |
|
220 |
208 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
117 |
115 |
$1K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
539 |
402 |
$1K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
30 |
30 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
752 |
660 |
$1K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
403 |
305 |
$1K |
| 83550 |
|
520 |
435 |
$1K |
| 87077 |
|
681 |
604 |
$1K |
| 87186 |
|
362 |
334 |
$1K |
| J3360 |
Injection, diazepam, up to 5 mg |
529 |
457 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,047 |
963 |
$1K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
15 |
14 |
$1K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
14 |
$1K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
37 |
37 |
$1K |
| 83540 |
|
540 |
449 |
$1K |
| 73080 |
|
122 |
119 |
$1K |
| 0071A |
|
25 |
25 |
$996.05 |
| 82248 |
|
277 |
232 |
$915.43 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
355 |
158 |
$802.69 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
53 |
26 |
$733.45 |
| 76775 |
|
29 |
29 |
$726.48 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
134 |
130 |
$711.26 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
134 |
130 |
$702.30 |
| 88304 |
|
124 |
113 |
$628.39 |
| 12001 |
|
29 |
28 |
$620.15 |
| 29515 |
|
61 |
55 |
$554.16 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
32 |
31 |
$522.17 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
243 |
132 |
$513.20 |
| 73590 |
|
41 |
39 |
$508.86 |
| 74220 |
|
17 |
12 |
$475.82 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,034 |
870 |
$453.63 |
| 72052 |
|
27 |
27 |
$407.86 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
28 |
25 |
$357.68 |
| 87999 |
|
229 |
225 |
$347.52 |
| 87420 |
|
211 |
206 |
$333.68 |
| 85651 |
|
206 |
191 |
$327.30 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
236 |
214 |
$327.08 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
258 |
234 |
$305.89 |
| 80164 |
|
46 |
41 |
$288.75 |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
18 |
18 |
$287.50 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,790 |
1,559 |
$258.64 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
39 |
38 |
$253.55 |
| 82607 |
|
87 |
80 |
$247.35 |
| 29125 |
|
69 |
67 |
$228.61 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
13 |
13 |
$216.49 |
| 72040 |
|
12 |
12 |
$175.49 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
39 |
38 |
$158.88 |
| 87581 |
|
30 |
30 |
$152.00 |
| 87486 |
|
30 |
30 |
$152.00 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
14 |
12 |
$142.94 |
| 84439 |
|
211 |
187 |
$140.07 |
| 83615 |
|
68 |
49 |
$139.77 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
46 |
42 |
$138.83 |
| 73090 |
|
27 |
26 |
$132.14 |
| J7510 |
Prednisolone oral, per 5 mg |
652 |
630 |
$132.11 |
| 85378 |
|
133 |
133 |
$127.09 |
| 82378 |
|
21 |
12 |
$119.32 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
174 |
148 |
$112.39 |
| 82150 |
|
129 |
126 |
$108.47 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
38 |
33 |
$95.71 |
| 82570 |
|
104 |
84 |
$93.62 |
| 86618 |
|
13 |
13 |
$91.14 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
119 |
94 |
$89.56 |
| 86308 |
|
141 |
130 |
$82.17 |
| 87205 |
|
54 |
54 |
$81.20 |
| 82247 |
|
17 |
12 |
$80.03 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
134 |
106 |
$78.46 |
| 86140 |
|
69 |
60 |
$74.12 |
| 82140 |
|
25 |
24 |
$72.64 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
83 |
42 |
$69.88 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
135 |
119 |
$67.70 |
| J1790 |
Injection, droperidol, up to 5 mg |
50 |
38 |
$66.80 |
| J3480 |
Injection, potassium chloride, per 2 meq |
60 |
38 |
$65.68 |
| 82803 |
|
14 |
13 |
$53.65 |
| OP637 |
|
8,525 |
1,579 |
$44.73 |
| J1630 |
Injection, haloperidol, up to 5 mg |
107 |
89 |
$41.95 |
| 84703 |
|
27 |
27 |
$35.67 |
| 80076 |
|
33 |
32 |
$35.12 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
29 |
28 |
$33.80 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
129 |
102 |
$13.10 |
| J3590 |
Unclassified biologics |
64 |
63 |
$12.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
32 |
24 |
$5.06 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
18 |
15 |
$3.35 |
| 87147 |
|
12 |
12 |
$3.00 |
| 91306 |
|
123 |
118 |
$1.00 |
| 91300 |
|
180 |
169 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
39 |
37 |
$0.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
18 |
17 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
13 |
12 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
26 |
12 |
$0.00 |
| 91301 |
|
632 |
624 |
$0.00 |
| 91307 |
|
69 |
64 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
118 |
101 |
$0.00 |